Streetbeat News

Stock Prices

GILD

A large investor has taken a bullish stance on Gilead Sciences (NASDAQ:GILD), with 10 uncommon options trades spotted. The sentiment of these trades is split 50% bullish and 50% bearish. The trades include 5 puts totaling $569,094 and 5 calls totaling $187,586. The targeted price range for Gilead Sciences over the last 3 months is from $70.0 to $105.0. The current price of GILD is down -0.7% at $79.63.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 7:20 pm

DLR

A significant bearish stance has been taken on Digital Realty Trust (NYSE:DLR) by a large investor or institution, as indicated by a large position in options. The sentiment among these big-money traders is 100% bearish, with 8 puts and 3 calls identified. The targeted price range for DLR over the last 3 months is $70.0 to $145.0. The current price of DLR is up 3.8% at $131.27. Morgan Stanley has maintained their Equal-Weight rating on DLR with a price target of $98.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 7:04 pm

AAPD

AAPL

AAPU

Apple Inc (AAPL) is set to release its Q4 financial results, with analysts estimating earnings per share of $1.31 on revenues of $84.18 billion. Wedbush analyst Daniel Ives reiterated an Outperform rating on the stock and maintained a price target of $240. Traders bullish on Apple may choose to take a position in Direxion Daily Apple Bull 1.5X Shares (AAPU), while bearish traders could opt for Direxion Daily Apple Bear 1X Shares (AAPD).

Portfolio Pulse from Melanie Schaffer

November 02, 2023 | 7:02 pm

ARKK

COIN

TARK

Coinbase Global, Inc (NASDAQ:COIN) is set to release its Q3 financial results, with analysts estimating earnings of 54 cents per share on revenues of $650.78 million. The company's stock was up over 8% ahead of the report. Citigroup analyst Peter Christiansen maintained a Neutral rating on Coinbase and lowered a price target from $105 to $90. Investors are keen to see how much of Coinbase's revenue was brought in through Bitcoin and Ethereum trading. The AXS 2X Innovation ETF (NASDAQ:TARK), which aims to return 200% of the daily performance of ARK Innovation ETF (NYSE:ARKK) and has Coinbase as its top holding, may be a diversified approach for bullish traders.

Portfolio Pulse from Melanie Schaffer

November 02, 2023 | 7:01 pm

AMGN

JNJ

The FDA has approved Amgen's biosimilar version of Johnson & Johnson's psoriasis treatment, Stelara, for multiple inflammatory diseases. This has led to a rise in Amgen's shares. Truist Securities analyst Robyn Karnauskas has upgraded Amgen's rating from Hold to Buy and raised the price target from $260 to $320.

Portfolio Pulse from Priya Nigam

November 02, 2023 | 7:01 pm

ONCY

Oncolytics Biotech (NASDAQ:ONCY) is set to release its quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The company's shares are currently trading at $1.62 and have seen a 41.27% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 7:01 pm

MOG

Moog Inc. Class A Common Stock (NYSE:MOG) is set to release its latest quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $1.71. The company's past performance shows a trend of missing EPS estimates, which has led to subsequent drops in share price. The stock is currently trading at $115.44 and has seen a 45.09% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 7:00 pm

CGNX

Analysts have provided mixed ratings for Cognex (NASDAQ:CGNX) in the last quarter, with 2 bullish, 3 indifferent, and 1 bearish. The average price target is $46.5, representing an upside from the current price of $35.41. This average is a 7.92% decrease from the previous average price target of $50.50.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 7:00 pm

CROUSD

Cryptocurrency Cronos (CRO) has seen a price increase of 5.23% in the last 24 hours, continuing its positive trend over the past week with an 11.0% gain. However, the trading volume for the coin has fallen 4.0% over the past week, along with a 0.41% decrease in circulating supply. The current market cap ranking for CRO is #34 at $1.69 billion.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 7:00 pm

APH

Amphenol (NYSE:APH) has outperformed the market over the past 15 years, producing an average annual return of 18.45%. If an investor had bought $100 of APH stock 15 years ago, it would be worth $1,312.52 today.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 7:00 pm